Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by ThisIsYerChanceon Feb 21, 2021 11:52am
235 Views
Post# 32621556

RE:Questions for Old Dog

RE:Questions for Old Dog
GrahamB wrote: Hi old dog,
 
Long time since we spoke.
Saw that you had posted on this VPT, recommending people buy in  over the HUGE website, so you stimulated me to look into it. 

Rather than post over on the other the HUGE website, I thought it folow- you over here, and give you my $0.02, FW IW
 
Took a quick look at your new company-but it didn’t pass my screen.

The major concerns that I would have about this company, would be the financials,, negative cash flow, the debt structure, insider sales, and the debentures and who is buying them.
Specificallyt:
 
1. How did you feel about the negative FCF of 484,000, and loss of about 1 million, and enlarging share count on recent financials in sedar?
They are dependent on financing to continue operating and required an emergency loan via CIBA in April.
 
2. They also have a statement of going concern:
 
 
‘ There is no certainty whether the Company will generate significant revenues or attain profitable operations in the near future and there can be no assurance that it will achieve profitability in the future, as it incurred a loss of $1,111,838 and had a negative cash flow from operating activities of $484,599 for the six months ended June 30, 2020, and has accumulated $39,059,088 of losses as at June 30, 2020. The Company's ability to continue as a going concern is dependent on its raising of future required capital, bringing its products to market and achieving and maintaining profitable operations. The outcome of these matters cannot be predicted at this time.”
 
Sedar.com
 
3.What about the debentures
 
“the Company issued $1,511,000 of convertible non-secured debentures (“Debentures I”) which mature on January 25, 2022, and issued a total of 9,066,000 common share purchase warrants (“Warrants I”) …
 
And
Debentures  were originally valued at the present value of the Debenture I interest and principal repayment cash flows, less transaction costs of $101,252 for a value of $957,748. Debentures I are accreted up to the face value of $1,511,000 over the life of the liability using the effective interest rate method, at an effective rate of 23.9%.” www.sedar.com
 
To me, 23.9% is a huge rate, even more than you pay on a credit card!  For a company that already has a negative cash flow to me this is a red flag.
 
Also who is buying the debentures “
 
Read this from SEDAR
“Two directors and officers of the Company purchased $383,000 of Debentures I under the offering.
Finders acting in connection with this offering received finder’s fees in the amount of 488,160 finder’s warrants. Each finder’s warrant is exercisable for one common share at an exercise price of $0.175 per common share until July 25, 2020. The finder’s warrants were valued at $30,000 by using the Black-Scholes model and recorded as Contributed Surplus (see (note 15))”
 
 
 
4.  The last question I would have relates to insider sales

Insider sales are also striking, which total in the millions, and I will not repeat them all because it is fairly extensive but of interest,
 
George Adams alone has sold over 4 million-for a company with a market cap of 7 million?
canadianInsider sales.com
(I can post thats eperately-but this is getting long
 
 
Listen I don’t have a bone in this dog fight-just doing a brief forensic on your recommendation that people here buy VPT
Old dog-looks like a dog to me, based on facts
 
Thanks for dropping by though, and for the tip, I think I will pass on this one

All mmy naive opinion, and dont liosten to me, I am an idiot, and do your own due diligence



Here is Graham's novel from Nov. 5th, 2020 when the SP was 9.5 cents. Sheesh. How much time did it take to write this, Lil Graham? It woulda took a lot less time to buy some shares. But it's your time and your money...

I make money buying and selling. How much do your opinions pay? For example, how is HUGE doing? I see you've been spamming your little opinions on that since 2018... cute.

<< Previous
Bullboard Posts
Next >>